No single antidepressant is universally “right” for everyone. The choice depends on your specific symptoms, whether you have other conditions like anxiety, your tolerance for certain side effects, and sometimes even what has worked for a close family member. Most people start with an SSRI, the most commonly prescribed class, and adjust from there based on how they respond over the first six to eight weeks.
Understanding how doctors narrow down the options can help you have a more productive conversation with whoever prescribes your medication. Here’s what actually goes into that decision.
Why SSRIs Are Usually the Starting Point
SSRIs (selective serotonin reuptake inhibitors) work by keeping more serotonin available in the brain, which gradually improves mood regulation. They replaced older antidepressants as the go-to first choice largely because they’re easier to tolerate and safer in overdose. Common SSRIs include sertraline, escitalopram, and fluoxetine.
That said, SSRIs aren’t the only option, and they’re not automatically the best fit for you. Other classes work on different brain chemicals or combinations of them, and the differences matter depending on what you’re dealing with.
How Your Symptoms Shape the Choice
One of the most practical ways doctors choose between antidepressants is by looking at which symptoms bother you most. Depression doesn’t look the same in everyone. Some people can’t sleep, others sleep too much. Some feel wired and agitated, others feel like they’re moving through mud. These differences point toward different medications.
If your depression comes with significant fatigue or low energy, bupropion is often considered. It works on dopamine and norepinephrine rather than serotonin, which gives it a mildly activating quality. It’s also one of the few antidepressants that doesn’t typically cause sexual side effects or weight gain, which makes it a common choice for people who’ve had those problems with SSRIs.
If insomnia is a major part of your depression, or you’ve lost a lot of weight, mirtazapine tends to be a better match. It has sedating properties that can help with sleep and also increases appetite. For someone who’s barely eating and lying awake at night, those “side effects” are actually benefits.
If your main struggle is anxiety alongside depression, SSRIs remain the first line. They’re effective for generalized anxiety, panic disorder, social anxiety, OCD, and PTSD. Sertraline, for example, has FDA approval for panic disorder, PTSD, social phobia, and OCD. Escitalopram is approved for generalized anxiety. Venlafaxine, an SNRI that works on both serotonin and norepinephrine, is another option with FDA approval for generalized anxiety, panic disorder, and social anxiety.
One wrinkle worth knowing: if you have panic disorder, you may be more sensitive to antidepressants at the start. Doctors often begin with a lower dose and increase it more slowly to avoid triggering panic attacks during the adjustment period.
Side Effects Often Drive the Decision
In practice, many antidepressants within the same class are roughly equally effective for depression itself. What separates them is their side effect profiles. This means your prescriber is often choosing not just “what will help” but “what will help without creating problems you can’t live with.”
The most common reasons people stop an antidepressant are sexual side effects (reduced desire or difficulty with orgasm), weight gain, drowsiness, or feeling emotionally flat. These vary considerably between medications. SSRIs and SNRIs are more likely to cause sexual side effects. Bupropion is less likely to. Mirtazapine and some older medications are more likely to cause weight gain. Some SSRIs like fluoxetine are mildly activating, while others like paroxetine are more sedating.
If you’ve tried an antidepressant before and stopped because of a specific side effect, that’s genuinely useful information. Tell your prescriber exactly what happened and why you stopped. It narrows the field considerably.
What Family History Can (and Can’t) Tell You
You may have heard that if a close relative did well on a particular antidepressant, you’re likely to respond to it too. This idea makes biological sense, since you share genetics that influence how your brain processes these medications. Small studies have suggested a connection between family members’ responses, and many clinicians use this as one factor in their decision.
However, a systematic review of the available research found that none of the studies were designed rigorously enough to definitively prove this link. The studies were small, and the evidence, while suggestive, isn’t conclusive. So if your parent or sibling had a great experience with a specific medication, it’s worth mentioning, but it’s not a guarantee.
The Six-to-Eight-Week Trial
One of the hardest parts of starting an antidepressant is the wait. Some people notice improvement within the first two to three weeks, but others don’t start feeling meaningfully better until three or four weeks in. A full trial of an antidepressant takes six to eight weeks at an adequate dose. If you haven’t seen significant improvement by then, your doctor should consider a change.
This timeline matters because many people give up too early, switching medications at three or four weeks when the drug hadn’t yet had a fair chance. Conversely, staying on something for months without benefit isn’t productive either. Six to eight weeks is the window that research supports for deciding whether a medication is working.
Side effects, on the other hand, often show up earlier and may fade over the first couple of weeks. Nausea, headaches, and increased anxiety at the start are common with SSRIs and frequently settle down. If a side effect is truly intolerable, though, you don’t need to white-knuckle through it for eight weeks. That’s a conversation to have with your prescriber sooner.
What Happens If the First One Doesn’t Work
Roughly a third of people respond well to their first antidepressant. If you’re not one of them, the next step is either switching to a different medication or adding a second one to boost the effect. Both strategies are common, and research suggests that adding a second medication (called augmentation) may be slightly more effective than switching entirely.
One large study comparing these approaches in older adults found that adding a low dose of a second medication was roughly as effective as adding bupropion to the existing antidepressant, and both augmentation strategies outperformed switching to bupropion alone. The takeaway: if a medication is partially working, building on it rather than starting over may be the better path.
Not responding to one antidepressant doesn’t mean you won’t respond to another. The medications differ enough in how they work that failure with one SSRI doesn’t predict failure with a different SSRI, let alone a different class entirely. Finding the right fit sometimes takes two or three tries.
A Note on Young Adults and Adolescents
The FDA requires a boxed warning on all antidepressants about an increased risk of suicidal thinking and behavior in children and adolescents. In clinical trials, the rate of suicidal thoughts or behavior in young people taking antidepressants was about 4%, compared to 2% on placebo. This risk is highest during the first few months of treatment or when doses change.
This doesn’t mean antidepressants are unsafe for young people. Untreated depression carries its own serious risks. But it does mean that close monitoring matters, especially early on. Increased irritability, agitation, or unusual behavior changes in the first weeks of treatment should be flagged to a prescriber right away.
How to Make the Conversation Productive
When you meet with a prescriber, the most useful things you can bring are specifics about your symptoms, your history with past medications (including ones prescribed for other conditions), your family’s experience with antidepressants if you know it, and which potential side effects concern you most. The choice isn’t just clinical. It’s personal. Someone who exercises daily and values their energy level may prioritize avoiding sedation. Someone who’s already struggling with insomnia may welcome it.
There is no blood test or quiz that reliably matches you to the perfect antidepressant on the first try. Pharmacogenetic testing, which analyzes how your genes process certain drugs, is marketed heavily but has limited evidence for improving outcomes in most cases. The process is still largely guided by your symptom profile, your medical history, and an informed conversation with someone who knows these medications well.